Literature DB >> 12706679

Protective immunity in cattle vaccinated with a commercial scale, inactivated, bivalent vesicular stomatitis vaccine.

James A House1, Carol House, Philippe Dubourget, Michel Lombard.   

Abstract

A commercially prepared oil-adjuvanted, inactivated vaccine containing antigens of vesicular stomatitis virus (VSV) serotypes New Jersey (NJ) and Indiana 1 (IND1) was administered to calves to determine its ability to induce protective immunity. Weekly serological studies were conducted. The 12 calves in Group I were vaccinated once and challenge inoculated with VSV New Jersey 28 days later. Two calves were fully protected and two were partially protected. The five calves in Group II were vaccinated twice 40 days apart and challenge inoculated on 14 days post-second vaccination (dp2v) with VSV Indiana 1. All animals were fully protected. The 14 calves in Group III were vaccinated twice 91 days apart and challenge inoculated on 91 dp2v with VSV Indiana 1. All animals were fully protected. All control calves in each group became clinically ill. Two calves inoculated with VSV Indiana 1 challenge virus on day 0 and 11 weeks later showed clinical disease after each inoculation. No virus was isolated from the blood of four acutely ill calves 48 h after challenge inoculation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706679     DOI: 10.1016/s0264-410x(03)00008-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.

Authors:  Minmin Zhang; Jinying Ge; Xiaofang Li; Weiye Chen; Xijun Wang; Zhiyuan Wen; Zhigao Bu
Journal:  Virol J       Date:  2016-02-24       Impact factor: 4.099

2.  Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.

Authors:  Xiaojuan Xue; Zhaorong Yu; Hongyan Jin; Lin Liang; Jiayang Li; Xiaolu Li; Yong Wang; Shangjin Cui; Gang Li
Journal:  BMC Vet Res       Date:  2021-01-18       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.